Tate & Lyle PLC
TATE: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|Nt | LOCK|D>Hnz | LOCK|s^w^W@K |
Tate & Lyle Earnings: In-Line Results, but Cautious Guidance Weighs on Share Price
Tate & Lyle reported a 5% revenue decline and 4% adjusted EBITDA growth in constant currency in fiscal 2025 (excluding CP Kelco), in line with guidance. Shares fell around 5% intraday on May 22, given cautious fiscal 2026 guidance amid tariff uncertainty.
